HIV drug resistance is a significant challenge in the management of HIV infections, particularly as antiretroviral therapy (ART) becomes more widely used. Drug resistance can occur when the virus ...

A meta-analysis found a low risk of HIV transmission in people taking antiretroviral therapy (ART) in high-income countries.

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

Drug regimens now offer more potent, less toxic and more durable choices in the treatment of HIV disease than ever before. This has led to a need to consider the convenient, sequential use of ...

Merck MRK announced positive topline data from two pivotal phase III studies evaluating the investigational, once-daily, oral, two-drug ... are on different antiretroviral therapy regimens ...

since the advent of ARV therapy (ART), treatment has evolved to become more tolerable. HIV-associated neurocognitive disorders consists of three levels of diagnosis. HIV-associated dementia has ...

Antiretroviral therapy, first introduced with the FDA's approval of AZT in 1987, was a turning point in HIV treatment. Over 50 antiretroviral drugs are now FDA-approved, offering a range of ...

It is too early to tell what impact the current HIV outbreak in Fiji may have on New Zealand, a charity at the forefront of New Zealand's response to the virus says. Fiji has recorded 1093 new HIV ...

The regional director of UNAIDS Asia Pacific Eamonn Murphy said rising new infections in Fiji "put the entire Pacific region ...